Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab [2]

Rheumatology

Volumn 40, Issue 4, 2001, Pages 473-474

  Robertson, L P ^a   Hickling, P ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOSPORIN; DAPSONE; INFLIXIMAB; THALIDOMIDE; TRIAMCINOLONE ACETATE;

ADULT; AGED; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENITAL ULCER; HUMAN; IMMUNOPATHOLOGY; LETTER; MOUTH ULCER; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MIDDLE AGED; ORAL ULCER; TUMOR NECROSIS FACTOR-ALPHA; ULCER;

EID: 0035042194     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. The expression of the γδ T cell receptor and prevalence of primed activated and IgA-bound T cells in Behçet's syndrome
2. Increased peripheral blood γδ T cells and natural killer cells in Behçet's disease
3. γδ T cell fraction of peripheral blood is increased in recurrent aphthous ulceration
4. Role of γδ T lymphocytes in the development of Behçet's disease
5. γδ T cells in Behçet's disease and recurrent aphthous stomatitis